Vimizim launch price 380000 2014?

How much did Vimizim cost at launch in 2014?

Vimizim (elosulfase alfa) launched in 2014 at a listed price of 380,000 (currency not specified in the information provided).

What does “380000” likely refer to (per year or per dose)?

The launch price figure “380000” is commonly reported as a yearly price in market-access and pricing discussions for enzyme replacement therapies, but the unit (per vial, per infusion, or per year) is not specified in your prompt.

Which market or country is the 2014 launch price for?

Drug launch prices vary by country and payer negotiations. The provided number alone does not indicate the specific country or reimbursement setting.

Can I confirm the exact launch price details if you share one more item?

If you tell me the country (or the source you’re using, like a report link or document name), I can restate the launch price accurately with the correct currency and whether it’s per year or per treatment.

Source

No source information was provided with the question, so I can’t verify the 2014 launch price beyond the number you supplied.